anti-TNFRSF25 antibody product blog
Tags: Antibody; DR3 (CT); anti-TNFRSF25 antibody; TNFRSF25;
The TNFRSF25 tnfrsf25 (Catalog #MBS194069) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s DR3 (CT) can be used in a range of immunoassay formats including, but not limited to, Immunoblot.Immunoblotting : use at 1:500-1:1,000 dilution.
Positive control: Whole cell lysate from Jurkat cells. Researchers should empirically determine the suitability of the TNFRSF25 tnfrsf25 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The TNFRSF25 tnfrsf25 product has the following accession number(s) (GI #37181738) (Uniprot Accession #Q93038). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Apoptosis, or programmed cell death, occurs during normal cellular differentiation and development of multicellular organisms. Apoptosis is induced by certain cytokines including TNF and Fas ligand of the TNF family through their death domaincontaining receptors, TNFR1 and Fas. Another cell death receptor was recently identified and designated DR3, Wsl-1, Apo- 3, TRAMP, and LARD. DR3 is widely expressed in tissues enriched in lymphocytes including peripheral blood, thymus, and spleen. Like TNFR1, DR3 induces apoptosis and NF- kappa B activation.
Antigen: Peptide corresponding the Cterminus of human DR3. Stabilizer: None
Preservatives: 0.02% sodium azide.
Dilutions Instructions: Dilute in PBS or medium which is identical to that used in the assay system. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing TNFRSF25 are readily searchable from our website. Different antibodies against the same target such as TNFRSF25 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. The following patways have been known to be associated with this gene. Blood, Brain, Connective Tissue, Embryonic Tissue, Heart, Intestine, Lung, Pancreas, Spleen, Thymus tissues are correlated with this protein. Adenocarcinoma, Arthritis, Rheumatoid, Carcinoma, Female Urogenital Diseases, Inflammation, Lymphoma, Male Urogenital Diseases, Neoplasms, Nervous System Diseases, Prostatic Neoplasms are some of the diseases may be linked to Anti-DR3 (CT) Antibody. TNFRSF25 also interacts with the following gene(s): BAG4, MAPK1, TNFRSF1A, TNFSF12, TNFSF15, TRADD, TRAF2.